Continue your Pharmapack Journey

In this workshop, we focus on achieving both environmental sustainability and patient well-being through innovative pharmaceutical packaging. Aligned with Berry Global’ s dedication to sustainability and innovation, we will discuss practical strategies for creating sustainable medical and pharmaceutica...

Sophrology is a modern and dynamic meditation practice which helps you tackle the challenges of today's world. This practice blends breathing exercises, gentle movement and positive visualization to help you de-stress your body, rewire your brain, transform the way you feel and unlock your full potential. ...

What are blister packs, and why are they so important? How have they changed over the years, and where are they heading? This presentation will consider a history of how blister packs have benefitted the supply of medicines to patients worldwide, and how they are continuing to evolve within an increasi...

Design Verification (DV) testing is the critical point in a Combination Product development program when all activities converge to generate the performance data necessary to support a successful regulatory filing. Any failure or delay during the DV stage of program has the potential to directly impact su...

The talk explores the current integration of digital health in drug delivery and various opportunities that it presents. Delving into the landscape of drug delivery, we examine the rise of connected devices, emphasizing the delicate balance between technology and compassionate care. This session also addre...

Abstract: Digital health solutions create myriad possibilities in terms of enabling “beyond the pill” health outcomes. However, the path to streamlining a strategic approach between pharma and its development partners toward creating smart combination products remains a challenge. With a general consensus ...

Meet industry sustainability experts in an informal setup for an open discussion on what matters the most for you as part of the Pharma industry. What are your current sustainability planning issues and how could you solve them? What could be your next steps and with whom do you need to collaborate to reac...

The healthcare landscape is experiencing a significant shift as traditional hospital-based care transitions to the home where feasible, enabled by innovative technologies supporting remote care, monitoring, and patient engagement. This talk aims to underscore the importance of preparing for this evolving e...

This session will bring together industry experts to discuss the opportunities and challenges that large-volume delivery devices have moving forward. Balancing technical and regulatory demands with ever-increasing pressures on cost-effective and sustainable solutions needs continued consideration. These to...

Proper definition of sterilization and max dose values is critical to the creation of a robust radiation sterilization process as part of your product’s route to market. Radiation Technology Center Senior Manager Pierre Reppert shares best practice for processing samples to define these values for gamma, e...

The investigation of the chemical compatibility between a drug product and its container relates to drug product quality, efficacy and safety - critical parameters for the development and commercialisation of a drug product. This implies assessing the extractables and leachables for each new drug produc...

Major players in the pharmaceutical supply chain are increasingly looking towards CPOs to outsource an essential step of drug production and distribution, but what are the opportunities and challenges to consider before moving forward?

"As a solution provider with a unique & dedicated product portfolio​, Gerresheimer is continuously exploring options to better accommodate their customers along the drug development and drug LCM journey. With its newly installed product platforms, Gerresheimer will be combining outstanding quality lev...

Learnings and experiences with establishing Takeback and Recycling systems for medical devices will be presented during this session, with a focus on regulatory, logistical and technical challenges and how to overcome them. Frode will also zoom in on the value of recycling and how to use the learnings t...

The proposed PPWR will overhaul everything about the way packaging is designed and used in the EU and is likely to influence global policy for many years. With tight targets for inclusion of recycled content for all industries, including pharmaceutical packaging from 2030, the industry is looking for safe ...

Bormioli Pharma has developed a solid and extensive patient-centric innovation program intended to advise the pharma industry along the entire drug development process, from early stage compatibility assessment up to the production of parts needed for drug fileing, clinical trials and commercialization. ...

Vaporized Hydrogen Peroxide (VHP or VH2O2) is a growing option for sterilizing pre-filled syringes that contain an aseptically filled biological product. The sterilization of the syringe exterior surfaces, packaging, and associated components allows for a sterile presentation to the patient reducing th...

Development of bio-therapeutics often rely on small-scale single-use bioreactors made from plastics that include versatile connectors for easy connection and fast turnaround. As bio-therapeutic development continues to grow, industry front runners have defined challenging sustainability environmental targe...

Get tools for quantifying user input for drug delivery systems – enabling sound choices in the development process. Imagine an elderly man, your grandfather, managing diabetes and self-injecting at home. While it's a simple task for the young and healthy, it poses challenges for the elderly. Incomplete ...

Sterile pharmaceutical production is expected to grow by over 50% in the next seven years, driven by new demand for recombinant antibodies and small molecules. Consequently, the fill/finish stage in pharmaceutical manufacturing is becoming a bottleneck in the pharmaceutical production . Health authorities ...

The pharmaceutical industry is in a transformation-phase, trying to move from linear to circular economy models. PharmaGuard is recognized as one of the leading polyolefin blister packaging solution, and recently has been rewarded with the ‘Prestigious German Packaging Award’ (Deutscher Verpackungspreis) i...

Per- and polyfluoroalkyl substances (PFAS) have long been integral in pharmaceutical packaging due to their unique properties. However, emerging regulatory changes in both the United States and the European Union have signaled a pivotal shift in the use of PFAS materials, particularly in pharmaceutical pac...

Wearables can take different shapes and sizes and are revolutionizing the way we monitor, treat, and manage health conditions. In this short deep dive, we will look at innovative wearable technologies and how they enable data collection and analysis, patient centric care, personalized medicine and more.

Today’s medicine and therapeutics encompass fairly complex formulations. The device design needs to not only incorporate the challenging needs of the formulation but also address patient optimized administration and deliver consistent results. The success of the clinical outcome is dependent on the deliver...

Towards a circular economy within the healthcare sector: What are the challenges? There is a fast-increasing awareness regarding the high environmental impact of our healthcare sector and the consequences it has. There is an urgent need for collaborative initiatives to reduce the environmental impact of...

Numerous drug technologies are advancing into pre-clinical and early clinical phases to enable new therapies with improved health outcomes. Those new technologies carry potential challenges pertaining to their compatibility with the container materials and with environmental conditions such as temperature ...

We are all willing to have sustainable products for the future. The open question is: how do we get there? This sustainability conference will start with inspiring experiences from sustainable healthcare initiatives. Presentations the focus on potential pathways and drivers for decarbonization of drug ...

Manufacturing processes are composed of a complex set of plastic materials that may introduce process-equipment related leachables (PERLs) into the final drug product, thereby potentially compromising its biocompatibility, safety or quality. At the same time, not all manufacturing components have the same ...

Learn about the different coating technologies for rubber stoppers, their unique features, and their applications in the pharmaceutical industry. Additionally, discover UltraShield™, Datwyler's latest development that meets the highest demands for drug compatibility and cold storage.

How can device and packaging innovation influence patient ability and motivation to use their treatment?" With examples from research of how patients learn and become motivated, and how industry can use these processes to influence patient outcomes. Patients learn through a mixture of stimuli and learning...

The presentation will highlight how we can use bio attributed polymers to reduce the carbon footprint without compromising product safety. With certified bio circular raw materials polymers can be produced to enable our customers to reduce their carbon footprint.

As the landscape, development, and introduction of large-volume delivery systems continue to grow, the implementation of these devices in the Pharma ecosystem creates unique challenges for pharmaceutical companies. From the selection of drug containment materials and enclosures, to device assembly needs to...

Drug development, particularly of biologics can be expensive and run over several years. One of the challenges for formulation and clinical development teams is identifying devices for use in early formulation and clinical studies, where the performance characteristics and clinical safety are being assesse...

This session will explore: • High Oxygen, CO2 and UV Barrier suitable for Biologics and Cell & Gene Therapies • Extremely Low Inorganic Extractables Suitable for Biologics and Cell & Gene Therapies • New Container Closure Integrity (CCI) Data at Deep Cold Storage (-80 degree C)

Edge Technologies, based on RFID (Radio Frequency Identification) and NFC (Near Field Communication) give medical devices and medicines a unique digital identity, and automatically read, sense, store and process, data locally on products, whilst enabling tracking and complex processing in the cloud or priv...

Product/patient safety is paramount, so how to balance the selection of packaging materials and systems with sustainability in mind? More sustainable solutions are coming online in different forms and need to be scaled into the market. Challenges on the innovation side focus on the validation of imp...

Let’s play it green: Realizing a decarbonized supply chain in parenteral drug administration Pharmaceutical companies are under significant pressure to address climate change and implement sustainable practices in their operations. They face the imperative of meeting commitments and stringent targets fo...

From sight, touch, taste, and smell to hearing, the five senses allow the body to take everything in. Research shows that the more senses are used, the better the memory is gathered, and the process enhanced. How does this theory apply to device development, design conception, and patient experience?

From unconscious bias to the gender pay gap, and lack of women in leadership roles – gender disparity continues to be a very real challenge faced by pharma. This panel will gather leaders from across the pharma packaging landscape to share their experiences of tackling inequality in the workplace, and to s...

This session will explore: • The role of the device supplier in overall product sustainability • Benefits of lifecycle assessment (LCA) in device development • Trade-offs between usability, cost of goods, and carbon footprint • Challenging Pharma to close the circle and enable better solutions

The validation of healthcare products and sterile barrier packaging prior to placing on the market is of the upmost importance to the safety of end user and patient. This presentation will give an overview of supporting testing and provide guidance on conducting successful studies.

Overcoming challenges when developing subcutaneous drug delivery devices that empower patient self-administration. The trend in parenteral patient therapy has been moving towards the home-care setting for some time as it empowers patient independence. However, home administration brings additional requi...

Pharma is guilty of gender disparity across its workforce and has historically been male dominated. Part of the problem could be that when it comes to roles in STEM, there still exists an ‘implicit bias’. How can we address the unconscious bias associated with the healthcare industry, and pave the way for ...

As more and more biotech is the origin for new products, completely different requirements are becoming important in the packaging process. These include handling sensitivity, integration of functionality into the pack, more combination packs and barrier protection. Those topics will be highlighted in the...

After years of investment in research & development, pharmaceutical companies have brought to the market a growing number of new therapies based on mRNA or viral vector technology, which require storage at freezing temperatures. Deep cold storage poses great challenges to the primary packaging container....

Eric Offermann and Bernd Zeiss will speak about Nitrogen Dioxide (NO2) as a new sterilization method and an alternative to EtO gas. A joint study carried out by Gerresheimer, Sterigenics and Früh, showed that NO2 is well suited to terminally sterilize prefilled ophthalmic syringes. The following 5 topics w...

Where are all the On Body Delivery Devices? On Body Large Volume Injectors (LVI) have been discussed and demonstrated for over ten years, but very few of these devices have reached the hands of patients. Two of CDPs combination product experts will outline the barriers that these products have faced in ...